Skip to content

Tobacco Dependence

Tobacco dependence is continued tobacco use driven by nicotine adaptation, cravings and learned cues despite harm or a wish to stop. It is treatable, and repeated quit attempts are common rather than evidence of failure.

Wellbutrin SR

Bupropion

150mg

Wellbutrin SR is bupropion 150mg in a modified-release tablet for tobacco dependence and major depression, a weak reuptake inhibitor of two amines.

From$1.12/ tabletView

Bupron SR

Bupropion

150mg

Bupron SR is bupropion 150mg in a prolonged-release tablet, used in the management of tobacco dependence. A weak noradrenaline and dopamine reuptake inhibitor.

From$1.06/ tabletView

Wellbutrin

Bupropion

150 · 300mg

Bupropion 150mg and 300mg modified-release tablets, used in the management of major depression and tobacco dependence. An aminoketone antidepressant.

From$1.06/ tabletView

Key points

  • Withdrawal may cause cravings, irritability, low mood, poor concentration, appetite change and sleep disruption.
  • A useful plan reviews all nicotine use, triggers, previous attempts, social support and the preferred goal and quit timing.
  • Nicotine replacement, varenicline and bupropion work differently; seizures, pregnancy, kidney function, mood and interactions affect choice.

Catalogue matches do not select a cessation medicine or provide a safe personal quit plan.

Why does dependence persist?

Nicotine reaches brain reward pathways quickly, while repeated pairings with meals, stress or social situations create strong cues. Withdrawal changes over time, but environmental and emotional triggers can remain and need practical alternatives.

How can medicine support quitting?

Bupropion may reduce withdrawal and cravings for selected adults but is unsuitable with some seizure or eating-disorder risks. Medicine works alongside coaching, trigger planning and follow-up; see addiction recovery.

When to seek urgent care

Seek urgent help for suicidal thoughts, seizure, severe allergic reaction, chest pain or serious breathing difficulty. Promptly report marked mood or behavioural change after starting treatment.

Further reading